Greenwood Capital Associates sold 21.9% of its Johnson & Johnson holdings in Q1, reducing their stake by over 15,000 shares.

Berkshire Hathaway’s energy portfolio is a tale of two strategies—one bold, one beautifully boring—and the latter is winning ...

Oracle just dropped its fiscal 2025 curtain and is already hyping fiscal 2026 with cloud-powered ambition. Morgan Stanley ...

AbbVie’s price target got a fresh boost as Citigroup raised it to $205, joining a chorus of analysts expressing optimism.

Merck shares fell 1.27%, lagging behind the S&P 500’s smaller dip of 0.27%. This decline comes despite Merck’s prior ...

Coca-Cola Europacific Partners just scooped up 49,789 of its own shares as part of a sizzling buyback move. The company ...

AMD and Cisco are diving headfirst into the Saudi cloud, joining forces with HUMAIN to develop AI infrastructure across the ...

Salesforce just turned some analyst heads with a forecasted earnings-per-share of $8.55 for FY2026, outpacing consensus by ...

Griffith & Werner Inc. increased its stake in Bank of America by 13.4%, acquiring 13,497 more shares to reach 114,556 in ...

Chevron faced a slight cold shoulder from Thompson Investment Management Inc., which trimmed its stake by 4.8% in Q1. Other ...

Thermo Fisher Scientific’s stock saw a modest rise of 0.22% after a rollercoaster trading session that started hot and ended ...

Vest Financial raised its stake in Wells Fargo by 73.5%, buying 11,547 more shares and now holding 27,256 worth $1.96 million ...